On 17 November, Yuan Linjiang, Chairman of China Re Group, was invited to attend the China Health Insurance Forum cum China Health Insurance Blue Book Press Conference, during which he delivered a keynote speech on “Showing the professional value of reinsurance and jointly supporting the Healthy China initiative”. Tian Meipan, general manager of China Re Life under China Re Group, also attended the meeting and gave a themed speech.

　　The meeting, jointly hosted by the National Institution for Finance and Development of the Chinese Academy of Social Sciences and Shanghai University of Medicine and Health Sciences, invited leaders, experts and scholars from the China Banking and Insurance Regulatory Commission, the National Health Commission and relevant research institutes, commercial insurance institutions and mainstream media to discuss the problems encountered in the course of development of China’s health insurance and their countermeasures and the construction of China’s health insurance ecosystem, and launched the China Health Insurance Blue Book (2020).

　　In his keynote speech, Chairman Yuan Linjiang said that, against the backdrop of the accelerated aging of China’s population, the per capita GDP exceeding US$10,000 and the continuous spread of COVID-19 around the world, health has become the focus of all sectors of society, and health insurance has become the golden track for China’s insurance industry. At present, commercial health insurance plays an increasingly important role in the national strategy of Healthy China driven by both policies and markets. As the “national team” of reinsurance, China Re Group has consistently played the role as the primary reinsurance channel. In particular, its market share of the domestic health reinsurance market has exceeded 40%. Through continuous exploration and implementation of new technologies, new products and new models, it has effectively promoted the industry infrastructure construction, innovative product development and innovative development of model in protecting people’s livelihood, and has actively contributed professional value to the strategy of Healthy China.

　　Chairman Yuan Linjiang further pointed out that in the future, China Re Group will continue to enhance research cooperation, industry collaboration and integration of industry and finance, working with all walks of life to jointly innovate, continuously help build a new health insurance ecosystem, with a view to making greater contribution to the Healthy China initiative.

　　Tian Meipan, general manager of China Re Life, gave a speech on the theme “The path to high-quality development of health insurance”, during which he comprehensively reviewed the historical opportunities of health insurance development, thoroughly analyzed the bottlenecks and challenges of health insurance development. He addressed the need to focus on the strategic balance between current and future development of health insurance, continuously deepen the supply-side reform of products, continue to promote the refined operation of long-term medical insurance and the scientific operation of health insurance, deepen the application of preferential tax policies, with a view to further strengthening industrial integration and medical integration as part of the efforts to support the high-quality development of commercial health insurance.